Olgu Sunumu
BibTex RIS Kaynak Göster

Open Heart Surgery In A Patient With Liver Transplantation: A Case Report

Yıl 2017, Cilt: 2 Sayı: 3, 87 - 88, 01.12.2017
https://doi.org/10.25000/acem.328007

Öz

As the
number of patients with liver transplantation increased, surgical applications were
also frequent due to late-onset heart and other systemic pathologies
.
The incidence of coronary artery disease is increasing in patients with liver
transplantation. Liver transplanted patients are a high risk subgroup for coronary
artery disease, even if they are asymptomatic. Coronary artery disease is a
predictor of poor outcomes in patients with liver transplantation; therefore,
identification of those patients at risk for coronary artery disease should be a
key clinical priority.
In this study, it was aimed to present coronary artery
bypass grafting surgery in a 68-year-old male patient with previous liver
transplantation 12 years ago.
Coronary artery bypass grafting operation
was performed using left internal mammarian artery and autogenous vein graft for
three vessels. There was no complication in the pre- and post-operative periods.
Coronary artery bypass grafting operation can be performed safely for patients
with previous liver transplantaion in experienced centers.

Kaynakça

  • 1. Prabhakar G, Testa G, Abbasoglu O, et al. The safety of cardiac operations in the liver transplant recipient. Ann Thorac Surg 1998; 65: 1060-4.
  • 2.Harrington PB, McAlexander WW, Bryant AS, et all. Outcomes of Patients Who Undergo Cardiac Surgical Procedures After Liver Transplantation. Ann Thorac Surg. 2017; 103: 541-5.
  • 3. Vogt DP, Henderson JM, Carey WD, Barnes D. The longterm survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132: 775-80.
  • 4. Canzanello VJ, Schwartz L, Taler SJ. et. all. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3: 1-9.
  • 5. Ota T, Rocha R, Wei LM, Toyoda Y, Gleason TG, Bermudez C. Surgical outcomes after cardiac surgery in liver transplant recipients Thorac Cardiovasc Surg. 2013; 145: 1072-6.
  • 6. Clarke AT, Mills PR. Atorvastatin associated liver disease. Dig Liver Dis 2006; 38: 772-7.
  • 7. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol 2006; 97: 52-60.
  • 8. Onofrei MD, Butler KL, Fuke DC, Miller HB. Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy 2008; 28: 522-9.

Karaciğer Nakli Yapılmış Bir Hastada Açık Kalp Cerrahisi: Bir Olgu Sunumu

Yıl 2017, Cilt: 2 Sayı: 3, 87 - 88, 01.12.2017
https://doi.org/10.25000/acem.328007

Öz

Karaciğer nakli olan
hasta sayısı arttıkça, geç dönemde gelişen kalp ve diğer sistem patolojileri
nedeniyle cerrahi uygulamaları da sıklaşmıştır. 
Karaciğer nakli olan hastalarda  koroner arter hastalığının görülme oranı
artmaktadır. Karaciğer transplantı hastaları, asemptomatik olsa bile, koroner
arter hastalığı için yüksek risk alt grubudur. Karaciğer transplantı gerçekleştirilen
bir hastada koroner arter hastalığı gelişmesi, kötü bir prognostik faktördür;
Bu nedenle, risk altındaki kişilerin belirlenmesi klinik önceliğe sahip
olmalıdır. Bu çalışmamızda,
 on iki yıl önce
karaciğer nakli uygulanan 68 yaşındaki bir erkek hastaya iskemik kalp hastalığı
tanısı ile kardiopulmoner bypass uygulanmasının sunulması amaçlanmıştır.
Hastaya sol internalmammarian arter ve otojenvengrefti kullanılarak üç damar
için koroner arter bypass greft cerrahisi uygulandı. Preoperatif ve
postoperatif herhangi bir komplikasyon gelişmedi.



Daha önce karaciğer
transplantasyonu yapılan hastalara, uygun merkezlerde koroner arter cerrahisi
güvenli bir şekilde yapılabilir. 

Kaynakça

  • 1. Prabhakar G, Testa G, Abbasoglu O, et al. The safety of cardiac operations in the liver transplant recipient. Ann Thorac Surg 1998; 65: 1060-4.
  • 2.Harrington PB, McAlexander WW, Bryant AS, et all. Outcomes of Patients Who Undergo Cardiac Surgical Procedures After Liver Transplantation. Ann Thorac Surg. 2017; 103: 541-5.
  • 3. Vogt DP, Henderson JM, Carey WD, Barnes D. The longterm survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132: 775-80.
  • 4. Canzanello VJ, Schwartz L, Taler SJ. et. all. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3: 1-9.
  • 5. Ota T, Rocha R, Wei LM, Toyoda Y, Gleason TG, Bermudez C. Surgical outcomes after cardiac surgery in liver transplant recipients Thorac Cardiovasc Surg. 2013; 145: 1072-6.
  • 6. Clarke AT, Mills PR. Atorvastatin associated liver disease. Dig Liver Dis 2006; 38: 772-7.
  • 7. Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol 2006; 97: 52-60.
  • 8. Onofrei MD, Butler KL, Fuke DC, Miller HB. Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy 2008; 28: 522-9.
Toplam 8 adet kaynakça vardır.

Ayrıntılar

Konular Cerrahi
Bölüm Olgu Sunumu
Yazarlar

Melike Elif Teker

Önder Teskin Bu kişi benim

Yayımlanma Tarihi 1 Aralık 2017
Yayımlandığı Sayı Yıl 2017 Cilt: 2 Sayı: 3

Kaynak Göster

Vancouver Teker ME, Teskin Ö. Open Heart Surgery In A Patient With Liver Transplantation: A Case Report. Arch Clin Exp Med. 2017;2(3):87-8.